ASCO 23: Thyroid cancer precision approaches that incorporate targeted therapies and other treatments are changing the surgeon’s role
DOWNLOADABLE B-ROLL/VIDEO
MIAMI, FLORIDA (June 1, 2023) – Historically, surgery was the first line of treatment for patients with thyroid cancer. Now, as targeted therapies and other new medications emerge, surgery for certain patients may become more of a secondary option if those treatments fail. This new context could potentially change how some procedures are conducted.
Otolaryngologist and head and neck surgeon Dr. Zoukaa Sargi, will join a June 2 panel discussion on thyroid cancer care ...















